retatrutide obesity triple hormone receptor agonist clinical trial results Retatrutide (Triple-Action Jab): Phase III Dr. Rutman | Weight Loss
Description
The real problem seems to be retention
While the concept behind the supplement seemed promising, my experience was less than satisfactory
Started my Retatrutide journey back in April weighing 218 pounds
Additionally, GLP-1 receptors in the gastrointestinal tract mediate delayed gastric emptying, which contributes to prolonged satiety and reduced postprandial glucose excursions
AACE: Comprehensive Type 2 diabetes management algorithm 2016
Liraglutide had the highest severe rate of gastrointestinal AEs (23.31%), while dulaglutide had the lowest, with a severe rate of 12.29%
